KEAP1 and cancer: However, KEAP1 LOF mutations or inactivation may disrupt this regulation, leading to NRF2 accumulation and sustained activation of pathways supporting cancer cell survival, including antioxidant synthesis, xenobiotic metabolism, and drug efflux.81